Skip to content
Get in touch

Research › Depression & Mood

An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study

Share

Suggested message

Check out this Knowledge Base article from StressTherapy Solutions: An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: A pilot study.

Facebook LinkedIn Email

Facebook doesn't let websites fill in your post. Use Copy message, then paste it in.

Study at a glance

Area
Depression & Mood
Study type
Pilot / open study
Authors
Spronk D, Arns M, Barnett KJ, Cooper NJ, Gordon E
Journal
Journal of Affective Disorders
Year
2011
Participants
25 patients with major depressive disorder (ages 18-65)
Population
Adults
Protocol
QEEG, ERP, genetic and neuropsychological markers of antidepressant response

Key findings

  • Better outcome was linked to a reduced auditory oddball N1 amplitude at baseline
  • The Met/Met variant of the COMT gene was the strongest genetic predictor
  • Impaired verbal memory was the best cognitive predictor, and raised frontal theta power the best EEG predictor
  • Combining N1 amplitude at Pz with verbal memory explained the largest share of variance

A pilot study of whether brain, genetic and cognitive measures can predict how well people with major depressive disorder respond to antidepressant medication. Twenty-five patients completed QEEG, event-related potential (ERP) and neuropsychological testing before treatment and at an 8-week follow-up, and gave cheek swabs for genetic analysis. Regression models identified which markers best predicted the drop in Hamilton Depression Rating Scale (HAM-D) scores. The authors suggest these markers could serve as new predictors of antidepressant outcome.